CA2435196A1 - Radical and etiological method of treatment for premature wrinkles and aging - Google Patents

Radical and etiological method of treatment for premature wrinkles and aging Download PDF

Info

Publication number
CA2435196A1
CA2435196A1 CA002435196A CA2435196A CA2435196A1 CA 2435196 A1 CA2435196 A1 CA 2435196A1 CA 002435196 A CA002435196 A CA 002435196A CA 2435196 A CA2435196 A CA 2435196A CA 2435196 A1 CA2435196 A1 CA 2435196A1
Authority
CA
Canada
Prior art keywords
treatment
wrinkles
face
products
misfortunes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002435196A
Other languages
French (fr)
Inventor
Thi Thanh Nguyen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THI THANH NGUYEN
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002435196A priority Critical patent/CA2435196A1/en
Publication of CA2435196A1 publication Critical patent/CA2435196A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

II- PRÉCIS DE L'INVENTION : 1- Psychologiquement les rides apparaissant précocement sur le visage fémini n rendent terriblement malheureuse la femme. Les souffrances, les malheurs, le s soucis, les angoisses etc... sont des causes qui engendrent les rides bien vite, et vis versa, de nouveau, ces derniers accentuent rapidement les malheurs. Ce qui crée un cercle vicieux, qui influence profondément sur la force de défense de l'organisme et sur le bonheur familial. Actuellement les médecin esthéticien injectaient des matières artificielles dangereuses comme silicone... sous la peau. Ce qui est un acte laissant beaucoup à désirer. 2- Cette méthode de thérapeutique spécifique et étiologique contre le vieillissement et les rides précoces sur la face des femmes consiste à utiliser une compositio n pharmaceutique de 2 produits synthétiques Chlordiazépoxide et Niamide et une gamme de 6 produits naturels : Sésamun Oriental, Glicyrrhiza, Grain de Lotus , Ganoderma Lucidum, Curcuma, Aloe. Ces 8 produits sont bien évalués et déterminées pour réactiver les cellules dermiques fatiguées et décontractée. Le traitement demande une durée courte : de 5 à 10 jours. 3- Le but de cette invention aide les personnes à rajeunir visage et corps. L'avantage de ce traitement non toxique est qu'il est capable de détruire les stress et la dystonie psychoneurovégétative. Ce qui leur donne plus de joie de vivre, de bonheur, plus d'intelligence, plus de force musculaire, de force d'autodéfen se et d'immunité. Car il régularise les système nerveux autonome et relève le système nerveux central. 2II- ACCURATE OF THE INVENTION: 1- Psychologically wrinkles appearing early on the female face make terribly unhappy woman. The sufferings, the misfortunes, the cares, the anxieties etc ... are causes which generate wrinkles very quickly, and vice versa, again, these quickly accentuate the misfortunes. This creates a vicious circle that profoundly influences the body's defense force and family happiness. Currently, the esthetician doctor injected dangerous artificial materials like silicone ... under the skin. Which is an act leaving much to be desired. 2- This method of specific and etiological treatment against aging and early wrinkles on the face of women consists of using a pharmaceutical composition of 2 synthetic products Chlordiazepoxide and Niamide and a range of 6 natural products: Sesamun Oriental, Glicyrrhiza, Grain de Lotus, Ganoderma Lucidum, Turmeric, Aloe. These 8 products are well evaluated and determined to reactivate tired and relaxed skin cells. The treatment requires a short duration: from 5 to 10 days. 3- The purpose of this invention helps people to rejuvenate face and body. The advantage of this nontoxic treatment is that it is able to destroy stress and psychoneuro-vegetative dystonia. What gives them more joy of life, happiness, more intelligence, more muscular strength, strength of self-defense and immunity. Because it regulates the autonomic nervous system and relieves the central nervous system. 2

Description

III- MÉMOIRE DESCRIPTIVE DE L'INVENTION
1- L'originalité de mon invention a été une découverte par hasard dans des conditions à la fois neurobiopathologique et clinique depuis plusieurs années (pas de publication) dans les traitement contre les états de dystonie psychoneurovëgétative. III- DESCRIPTIVE MEMORY OF THE INVENTION
1- The originality of my invention was a discovery by chance in terms at the same time neurobiopathological and clinical for several years (no publication) in treatment against states of dystonia psychoneurovëgétative.

2- Cette originalité de concept provient d'une occasion spéciale. En 1972, un jour l'étais dans un état de dépression, j'ai essayé préparer moi-même un médicament pour moi : Les produits naturel et Chlordiazéoixide et Niamide. Le résultat est magnifique : Se regardant dans le miroir, je me voir en bonne mine, joyeuse et rajeunie de 10 ans. J'ai pratiqué ce traitement sur plusieurs amies malheureuses et vieillies précocement. Le résultat est toujours satisfait. Ce qui est plus intéressant c'est que la femme traitée est à la fois rajeunie et en très bonne santé. 2- This originality of concept comes from a special occasion. In 1972, a day was in a state of depression, I tried to prepare myself a drug for me: Natural products and Chlordiazéoixide and Niamide. The result is beautiful: Looking in the mirror, I see myself looking good, happy and younger than 10 years. I practiced this treatment on several friends unhappy and aged early. The result is always satisfied. What's more interesting it is that the treated woman is at once rejuvenated and in very good health.

3- Mon invention a un caractére totalement exclusif. Personne ne pense à un traitement pareil. Ainsi je pourrais souhaiter avoir la bienveillance du Commissaire des Examinateurs dans l'octroi d'un brevet demandé. 3- My invention has a totally exclusive character. Nobody thinks of a treatment the same. So I might wish to have the kindness of the Commissioner of Examiners in granting a requested patent.

Claims (2)

1- Utilisation d'une composition de deux produits pharmaceutiques synthétiques :
Chlordiazépoxide et Niamide, et de trois naturels : Grain de Lotus, Ganoderma Lucidum, Curcuma. 1- Use of a composition of two synthetic pharmaceutical products :
Chlordiazepoxide and Niamide, and three natural: Lotus Grain, Ganoderma Lucidum, Turmeric. 2- Utilisation d'une composition de deux produits pharmaceutiques synthétiques Chlordiazépoxide et Niamide, et de 6 naturels : Sésamun Oriental, Glicyrrhiza, Grain de Lotus, Ganoderma Lucidum, Curcuma, Aloe. 2- Use of a composition of two synthetic pharmaceutical products Chlordiazepoxide and Niamide, and 6 natural: Sesamun Oriental, Glicyrrhiza, Grain of Lotus, Ganoderma Lucidum, Turmeric, Aloe.
CA002435196A 2003-07-21 2003-07-21 Radical and etiological method of treatment for premature wrinkles and aging Abandoned CA2435196A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002435196A CA2435196A1 (en) 2003-07-21 2003-07-21 Radical and etiological method of treatment for premature wrinkles and aging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002435196A CA2435196A1 (en) 2003-07-21 2003-07-21 Radical and etiological method of treatment for premature wrinkles and aging

Publications (1)

Publication Number Publication Date
CA2435196A1 true CA2435196A1 (en) 2005-01-21

Family

ID=34069897

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002435196A Abandoned CA2435196A1 (en) 2003-07-21 2003-07-21 Radical and etiological method of treatment for premature wrinkles and aging

Country Status (1)

Country Link
CA (1) CA2435196A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3010482A4 (en) * 2013-06-19 2016-11-02 Stemtech International Inc Methods and compositions for enhancing stem cell mobilization

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3010482A4 (en) * 2013-06-19 2016-11-02 Stemtech International Inc Methods and compositions for enhancing stem cell mobilization

Similar Documents

Publication Publication Date Title
Santos et al. Nanotechnology for the development of new cosmetic formulations
CN100336521C (en) Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
US8795679B2 (en) Pharmaceutical and cosmetic use of extracts from algae obtainable from saline hot water sources
KR102394532B1 (en) Cosmetic composition containing hyaluronic acids having different molecular weight
BRPI0417666A (en) oral or personal treatment composition, method for administering a functional material to a human or animal subject, and process for preparing a oral or personal treatment composition
EP3370833B1 (en) Synergistic extract of palmaria palmata
WO2014199022A1 (en) Method for cross-linking hyaluronic acid, method for preparing an injectable hydrogel, resulting hydrogel and use thereof
FR3080285A1 (en) COSMETIC COMPOSITION COMPRISING AN AQUEOUS EXTRACT OF ROSE FRUIT
CA2136706C (en) Process for controlling adiposity and compositions for use therein
WO2013004953A2 (en) Cosmetic composition comprising a mixture of honeys
Bagheri et al. Protective effect of quercetin on alteration of antioxidant genes expression and histological changes in the dental pulp of the streptozotocin-diabetic rats
Jordan Soft-tissue fillers for wrinkles, folds and volume augmentation
WO2010094246A4 (en) Tooth stump structure, production method and design thereof
CA2435196A1 (en) Radical and etiological method of treatment for premature wrinkles and aging
EP2254584B1 (en) Biocompatible injectable products with zinc and/or zinc-form saccharide-salt release, and uses thereof
FR2844198A1 (en) Restricting complement activating side-effects in skin, mucosa and/or scalp, e.g. for combating irritation due to other active agents, using activator of production of protectin or its precursor
RU2290170C1 (en) Cosmetic agent possessing with rejuvenating effect and method for its preparing
FR3091172B1 (en) Solid cosmetic composition consisting of a solid aqueous continuous phase
WO2016073801A1 (en) Low-level laser irradiation of stimulated human stem cells
US20050053564A1 (en) Use a plant extract to enhance hair growth and hair restoration for damaged hair
TWI674104B (en) Skin sagging or aging improver due to dermal hollowing out of adipose stem cell attractant
EP1551365A1 (en) Method for cosmetic body treatment to enhance the silhouette and to develop the female bust, and double-acting cosmetic composition therefor
FR2729568A1 (en) Green clay-based compsn. for use in e.g. mud-baths, poultice(s), plasters and face-packs
Jain et al. An Overview Of Medicinal Plants Used For Anti-Aging Face Pack Formulation
Kamalii et al. APPLICATIONS OF COSMECEUTICALS DERIVED FROM MARINE RESOURCES

Legal Events

Date Code Title Description
FZDE Dead